MicroCHIPS claims that the current patent in combination with US patent no. 7,070,590 offers coverage for the design and fabrication of reservoir-based medical devices used for implantable drug delivery systems.
MicroCHIPS’ intellectual property originated as patent filings at the Massachusetts Institute of Technology, by professors and MicroCHIPS cofounders Robert Langer and Michael Cima, and cofounder John Santini.
MIT, David H. Koch Institute for Integrative Cancer Research, Sumitomo Electric Industries Engineering, Professor Michael Cima said this patent and technology portfolio combined with the on-going MicroCHIPS clinical trial focused on delivery of human parathyroid hormone will demonstrate the viability of controlled release from programmable or pre-programmable devices.